These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21615076)

  • 1. Mining for bioactive scaffolds with scaffold networks: improved compound set enrichment from primary screening data.
    Varin T; Schuffenhauer A; Ertl P; Renner S
    J Chem Inf Model; 2011 Jul; 51(7):1528-38. PubMed ID: 21615076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivity-guided navigation of chemical space.
    Bon RS; Waldmann H
    Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining horizontal and vertical substructure relationships in scaffold hierarchies for activity prediction.
    Hu Y; Bajorath J
    J Chem Inf Model; 2011 Feb; 51(2):248-57. PubMed ID: 21271729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scaffold tree: an efficient navigation in the scaffold universe.
    Ertl P; Schuffenhauer A; Renner S
    Methods Mol Biol; 2011; 672():245-60. PubMed ID: 20838972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically.
    Hu Q; Peng Z; Kostrowicki J; Kuki A
    Methods Mol Biol; 2011; 685():253-76. PubMed ID: 20981528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the bioactivity-relevant chemical space of robust reactions and common molecular building blocks.
    Hartenfeller M; Eberle M; Meier P; Nieto-Oberhuber C; Altmann KH; Schneider G; Jacoby E; Renner S
    J Chem Inf Model; 2012 May; 52(5):1167-78. PubMed ID: 22512717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold network generator: a tool for mining molecular structures.
    Matlock MK; Zaretzki JM; Swamidass SJ
    Bioinformatics; 2013 Oct; 29(20):2655-6. PubMed ID: 23918250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of bioactive small molecule target through phenotypic screening.
    Cho YS; Kwon HJ
    Bioorg Med Chem; 2012 Mar; 20(6):1922-8. PubMed ID: 22153994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds.
    Ertl P; Jelfs S; Mühlbacher J; Schuffenhauer A; Selzer P
    J Med Chem; 2006 Jul; 49(15):4568-73. PubMed ID: 16854061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning from the data: mining of large high-throughput screening databases.
    Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
    J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward an efficient approach to identify molecular scaffolds possessing selective or promiscuous compounds.
    Yongye AB; Medina-Franco JL
    Chem Biol Drug Des; 2013 Oct; 82(4):367-75. PubMed ID: 23659738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound set enrichment: a novel approach to analysis of primary HTS data.
    Varin T; Gubler H; Parker CN; Zhang JH; Raman P; Ertl P; Schuffenhauer A
    J Chem Inf Model; 2010 Dec; 50(12):2067-78. PubMed ID: 21073183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening and scaffold hopping based on GRID molecular interaction fields.
    Ahlström MM; Ridderström M; Luthman K; Zamora I
    J Chem Inf Model; 2005; 45(5):1313-23. PubMed ID: 16180908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of computational methods in the identification of bioactive compounds.
    Glick M; Jacoby E
    Curr Opin Chem Biol; 2011 Aug; 15(4):540-6. PubMed ID: 21411361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular scaffold analysis of natural products databases in the public domain.
    Yongye AB; Waddell J; Medina-Franco JL
    Chem Biol Drug Des; 2012 Nov; 80(5):717-24. PubMed ID: 22863071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology-oriented synthesis.
    Wetzel S; Bon RS; Kumar K; Waldmann H
    Angew Chem Int Ed Engl; 2011 Nov; 50(46):10800-26. PubMed ID: 22038946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.